biovisionK704-200CYP2D inhibitor screening kit, CYP2D6 inhibitor kit, CYP inhibitor screening, screen cytochrome P450 inhibitors, study Cytochrome P450 2D6 inhibitors, characterize CYP inhibitors, characterize CYP ligands. CYP2D6 inhibitor, CYP2D inhibitor screening kit, cyp2d inhibitor kit, cytochrome inhibitor screening, screen cyp2d inhibitors, screen cyp2d ligands, screen CYP2D6 inhibitors, CYP2D6 ligands, study cytochrome P450 2D6 inhibitors, characterize cyp2d6 inhibitors, Cyt P450 inhibitor, Cyt P450 2D6 drug screening, Cytochrome P450 ligand screening kit, CypIID6 ligand screening kit, CYP2D6 inhibitor screening, screen inhibitors of CYP enzymes, study cytochrome P450 inhibitors, characterize CYP inhibitors, Cytochrome P450 ligands, cytochrome P450 2D6, July-AK-15? Detection method - Fluorescence (Ex/Em 390/468 nm) ? Species reactivity - Eukaryotes ? Applications - ? Rapid, high-throughput screening of drugs and novel ligands. ? Development of structure-activity relationship (SAR) models to predict CYP2D6 inhibition liability of novel compounds. ? Prediction of adverse drug-drug interaction potential and bioavailability for compounds metabolized by CYP2D6. ? Rapid, high-throughput screening of drugs and novel ligands. ? Development of structure-activity relationship (SAR) models to predict CYP2D6 inhibition liability of novel compounds. ? Prediction of adverse drug-drug interaction potential and bioavailability for compounds metabolized by CYP2D6.Samples containing drugs, inhibitors or ligands (compounds that can interact and affect CYP2D activity)